{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:25:23Z","timestamp":1788452723007,"version":"build-2803163510"},"reference-count":21,"publisher":"American Medical Association (AMA)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Otolaryngol Head Neck Surg"],"abstract":"\n Importance<\/jats:title>\n Total thyroidectomy with bilateral central neck dissection is recommended for medullary thyroid carcinoma (MTC), even in patients without clinical nodal involvement. However, the role of contralateral prophylactic central neck dissection (pCND) remains debated, leading to variations in practice.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate the outcomes of nodal dissection in compartment-specific recurrence in patients undergoing surgical treatment for MTC, including a subgroup analysis of patients with preoperative clinically node-negative (cN0) disease stratified by whether they underwent contralateral pCND.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This was a multicenter retrospective cohort study of adult patients with MTC who underwent thyroidectomy between 1998 and 2021 in 4 academic referral centers. Data were analyzed from February to July 2026. Patients with missing operative data, including initial thyroidectomy information and central neck dissection laterality, were excluded.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Contralateral pCND at the time of initial surgical treatment.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n \n Recurrence categorized as biochemical (calcitonin &amp;gt;2 pg\/mL without radiographic findings); ipsilateral central, ipsilateral lateral, contralateral central, and contralateral lateral neck; and distant metastatic. Effect size was reported as Rosenthal\n r<\/jats:italic>\n (\n r<\/jats:italic>\n ) for continuous variables and as risk difference (RD) with 95% CIs for categorical variables. Multivariable Cox regression was used to evaluate risk factors for contralateral neck recurrence and overall recurrence.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n This study in a total of 235 patients who underwent surgical treatment for MTC (132 [56%] female; median age, 56 years [IQR, 43-66 years]) found that, preoperatively, 105 patients (45%) had cN0 disease, of whom 58 (55%) underwent contralateral pCND. Genetic testing was performed in 127 (54%) patients, with a 25% rate of germline\n RET<\/jats:italic>\n variant. Overall, 73 patients (31%) developed disease recurrence: 15% in the ipsilateral central, 15% ipsilateral lateral, 5% contralateral central, and 8% contralateral lateral neck; 11% distant metastatic; and 4% biochemical. Among patients with cN0 disease, differences in the rates of overall recurrence (22% vs 15%; RD, 0.07; 95% CI, \u22120.07 to 0.22) and contralateral central neck recurrence (5% vs 2%; RD, 0.03; 95% CI, \u22120.04 to 0.10) were small and imprecisely estimated between those who did and did not undergo contralateral pCND. On multivariable analysis adjusting for sex, tumor size, and nodal involvement, contralateral pCND was not associated with reduced overall recurrence (hazard ratio [HR], 0.59; 95% CI, 0.21-1.62) or contralateral neck recurrence (HR, 0.23; 95% CI, 0.02-3.08).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This study found that, in MTC, the most frequent sites of recurrence were the ipsilateral central and lateral neck. Contralateral central neck recurrence was uncommon; however, our wide CIs preclude definitive conclusions about the benefit of contralateral pCND, and larger studies are warranted.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamaoto.2026.2597","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:03:47Z","timestamp":1788451427000},"source":"Crossref","is-referenced-by-count":0,"title":["Compartment-Specific Recurrence in Medullary Thyroid Cancer"],"prefix":"10.1001","author":[{"given":"Young-Ji","family":"Seo","sequence":"first","affiliation":[{"name":"Section of Endocrine Surgery, UCLA David Geffen School of Medicine, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey N.","family":"Larios","sequence":"additional","affiliation":[{"name":"Section of Endocrine Surgery, UCLA David Geffen School of Medicine, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan V.","family":"Mao","sequence":"additional","affiliation":[{"name":"Section of Endocrine Surgery, UCLA David Geffen School of Medicine, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehia K.","family":"Elkersh","sequence":"additional","affiliation":[{"name":"Department of Surgery, Icahn School of Medicine at Mount Sinai Hospital, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce","family":"England","sequence":"additional","affiliation":[{"name":"Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena G.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Section of Endocrine Surgery, UCLA David Geffen School of Medicine, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra N.","family":"Lim","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, UCLA David Geffen School of Medicine, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masha J.","family":"Livhits","sequence":"additional","affiliation":[{"name":"Section of Endocrine Surgery, UCLA David Geffen School of Medicine, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Yeh","sequence":"additional","affiliation":[{"name":"Section of Endocrine Surgery, UCLA David Geffen School of Medicine, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor E.","family":"Angell","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, Keck School of Medicine, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q. Lina","family":"Hu-Bianco","sequence":"additional","affiliation":[{"name":"Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Surgery, Icahn School of Medicine at Mount Sinai Hospital, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James X.","family":"Wu","sequence":"additional","affiliation":[{"name":"Section of Endocrine Surgery, UCLA David Geffen School of Medicine, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"issue":"6","key":"ooi260051r1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"issue":"3","key":"ooi260051r2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/jamaoto.2023.4376","article-title":"Extent of surgery for medullary thyroid cancer and prevalence of occult contralateral foci.","volume":"150","author":"Mao","year":"2024","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"8","key":"ooi260051r3","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00268-002-6665-1","article-title":"Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations.","volume":"26","author":"Miyauchi","year":"2002","journal-title":"World J Surg"},{"key":"ooi260051r4","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2025.109699","article-title":"Highly-selected sporadic, apparently unifocal cN0 MTC may benefit from unilateral surgery. A proof of concept in a high-volume institution.","volume":"189","author":"Rossi","year":"2026","journal-title":"Surgery"},{"issue":"1","key":"ooi260051r5","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2017.3555","article-title":"Risk factors for reoperation in patients with medullary thyroid carcinoma.","volume":"153","author":"Kuo","year":"2018","journal-title":"JAMA Surg"},{"issue":"9","key":"ooi260051r6","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1093\/bjs\/znab106","article-title":"Medullary thyroid cancer outcomes in patients with undetectable versus normalized postoperative calcitonin levels.","volume":"108","author":"Fanget","year":"2021","journal-title":"Br J Surg"},{"issue":"1","key":"ooi260051r7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1037\/a0024338","article-title":"Effect size estimates: current use, calculations, and interpretation.","volume":"141","author":"Fritz","year":"2012","journal-title":"J Exp Psychol Gen"},{"issue":"5","key":"ooi260051r8","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1210\/jc.2002-021713","article-title":"Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.","volume":"88","author":"Scollo","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"ooi260051r9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1433329","article-title":"Thyroidectomy without lymph node dissection should be considered for stage T1 medullary thyroid carcinoma: a population-based cohort study.","volume":"15","author":"Tao","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"ooi260051r10","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1001\/jamasurg.2017.1665","article-title":"Rethinking the current American Joint Committee on Cancer TNM staging system for medullary thyroid cancer.","volume":"152","author":"Adam","year":"2017","journal-title":"JAMA Surg"},{"issue":"7","key":"ooi260051r11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1089\/thy.2024.0076","article-title":"Anatomical patterns of nodal spread in unilateral papillary and medullary thyroid cancer.","volume":"34","author":"Machens","year":"2024","journal-title":"Thyroid"},{"issue":"3","key":"ooi260051r12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.6004\/jnccn.2024.7088","article-title":"Hemithyroidectomy versus total thyroidectomy for sporadic medullary thyroid cancer: a Chinese nationwide large-scale cohort study.","volume":"23","author":"Shi","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"ooi260051r13","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.surg.2022.06.023","article-title":"Total thyroidectomy vs thyroid lobectomy for localized medullary thyroid cancer in adults: a propensity-matched survival analysis.","volume":"172","author":"Liang","year":"2022","journal-title":"Surgery"},{"issue":"12","key":"ooi260051r14","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1007\/s00268-018-4738-z","article-title":"Static prognostic factors and appropriate surgical designs for patients with medullary thyroid carcinoma: the second report from a single-institution study in Japan.","volume":"42","author":"Ito","year":"2018","journal-title":"World J Surg"},{"issue":"7","key":"ooi260051r15","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1007\/s00423-022-02591-9","article-title":"Surgical selection and prognostic analysis in patients with unilateral sporadic medullary thyroid carcinoma.","volume":"407","author":"Zhang","year":"2022","journal-title":"Langenbecks Arch Surg"},{"issue":"2","key":"ooi260051r16","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1089\/thy.2014.0277","article-title":"Response to initial therapy predicts clinical outcomes in medullary thyroid cancer.","volume":"25","author":"Lindsey","year":"2015","journal-title":"Thyroid"},{"issue":"10","key":"ooi260051r17","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1245\/s10434-009-0595-1","article-title":"Micromedullary thyroid cancer: how micro is truly micro?","volume":"16","author":"Pillarisetty","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"ooi260051r18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1001\/jamaoto.2025.5599","article-title":"Total thyroidectomy vs lobectomy for sporadic medullary thyroid cancer: a systematic review and meta-analysis.","volume":"152","author":"Lincango","year":"2026","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"6","key":"ooi260051r19","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.surg.2023.09.003","article-title":"Sporadic noninvasive medullary thyroid neoplasm: a desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy.","volume":"174","author":"Dralle","year":"2023","journal-title":"Surgery"},{"issue":"8","key":"ooi260051r20","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/jamaoto.2025.0542","article-title":"Updated thresholds of basal calcitonin level and extent of lymph node metastasis in initially treated medullary thyroid cancer.","volume":"151","author":"Du","year":"2025","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"3","key":"ooi260051r21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010159.pub2","article-title":"Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules.","volume":"3","author":"Verbeek","year":"2020","journal-title":"Cochrane Database Syst Rev"}],"container-title":["JAMA Otolaryngology\u2013Head & Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/articlepdf\/2853312\/jamaotolaryngology_seo_2026_oi_260051_1787168733.81486.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:03:49Z","timestamp":1788451429000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/fullarticle\/2853312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":21,"URL":"https:\/\/doi.org\/10.1001\/jamaoto.2026.2597","relation":{},"ISSN":["2168-6181"],"issn-type":[{"value":"2168-6181","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,3]]}}}